White-label platform
A flat-fee, branded health platform clients can own.
Who it's for
Give the employers and clients you advise a branded health platform they can launch under their own name, while an independent board-certified network licensed in all 50 states delivers all clinical care. You broker and advise; the network owns the clinical.
$0 to start$0 until you're liveno cardcancel anytime
Wellstaq is a white-label clinical platform that lets benefits brokers & consultants offer labs, telehealth, 503A Rx and supplements under their own brand, while an independent, board-certified network licensed in all 50 states owns all clinical decisions and prescribing.
Your recurring upside
Start with your core program, then stack the layers you own. Drag the member count and toggle each layer — every figure is illustrative and set by you.
Branded health benefit = membership, visits & monitoring.
Illustrative — you set your own pricing. Not a guarantee of earnings. Figures are your recurring program revenue (membership, monitoring, labs, supplements and adjacent care), not promised drug margin. Labs and supplements pass through at wholesale; you set retail and keep the margin. Wellstaq takes 0% of your sales.
At a $99/mo program,
just 21 members
cover your entire $2,000/mo platform fee. Every member after that is your margin.
Illustrative — you set your own pricing. Not a guarantee of earnings.
A proven model
Function Health turned telehealth and recurring prescriptions into billion-dollar brands. You get that same model — plus blood labs, genetic reports and a branded supplement line they don't bundle — under your own name, with an independent 50-state network owning all clinical care.
Billion-dollar brands — built on years of venture capital.
Launch in weeks, for a flat fee — no raise required.
Clients increasingly ask for more than traditional plans, and you want differentiated offerings to bring to renewals. A white-label health platform gives you something new to broker. Each client becomes the brand layer for their own program while the independent network owns all clinical care and PHI. You stay in your role as broker and advisor and never sit inside clinical workflows.
$50B+ corporate wellness market (illustrative)
You bring the platform to clients as part of your offering and advise on fit.
Each employer or client launches the program under their own brand.
An independent, board-certified network licensed in all 50 states delivers all evaluation, prescribing and PHI handling.
A flat-fee, branded health platform clients can own.
Licensed in all 50 states; delivers all clinical care.
Wholesale lab access and network-run consults.
A simple flat platform fee that is easy to present.
You're really choosing between sending patients to someone else's brand, building it all yourself, or owning the model on Wellstaq.
How the economics work
$2,000/mo flat platform fee — the only cut we take. Blood labs, telehealth and supplements pass through at true wholesale cost; you set retail and keep the margin. Wellstaq takes 0% of your sales.
You broker and advise. The independent board-certified network delivers all clinical care, prescribing and PHI. Neither you nor your client acts as a provider.
No. The independent network carries clinical liability and PHI. Your clients stay the brand layer for their own program.
A flat $2,000/mo, wholesale pass-through, and 0% of your sales. Get on the list before spots open.
$0 to start$0 until you're liveno cardcancel anytime
You are the brand and marketing layer only. The independent, board-certified provider network licensed in all 50 states owns all clinical care and prescribing. Your brand makes no drug, medical, efficacy or outcome claims, and offers no product before a provider evaluation. Wellstaq provides technology and brand infrastructure. All clinical decisions, evaluations and prescribing are made by an independent, board-certified provider network licensed in all 50 states. Wellstaq and its partners make no diagnosis, treatment, efficacy or outcome claims; nothing here is medical advice.